Novanta (NOVT) Stock Price

Novanta Price

NASDAQ·CLOSED
152.58USD+4.22 (+2.80 %)
Market closed

Revenue has compounded at 6.2% per year over the past 19 years to 980.60 M USD. Earnings per share have declined at 0.5% per year over the last 19 years. Novanta's net margin stands at 5.5%, down from 7.1% several years earlier. Analysts set a median price target of 161.67 USD, implying 6.0% above the current price. Of 10 analysts, 7 rate the stock a buy — an overall Buy consensus. Over the past year Novanta shares have gained 32.7%. The stock trades about 54% above its 52-week low.

Novanta stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Novanta over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Novanta stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Novanta's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Novanta Stock Price History
DateNovanta Price
9/8/2026152.58 USD
9/4/2026148.36 USD
9/3/2026147.24 USD
9/2/2026144.52 USD
9/1/2026143.67 USD
8/31/2026146.22 USD
8/30/2026144.58 USD
8/28/2026144.00 USD
8/27/2026144.43 USD
8/26/2026143.96 USD
8/25/2026139.65 USD
8/24/2026142.62 USD
8/21/2026145.24 USD
8/20/2026145.52 USD
8/19/2026150.76 USD
8/18/2026160.14 USD
8/14/2026166.58 USD
8/13/2026167.25 USD
8/12/2026167.04 USD
8/11/2026167.71 USD
8/10/2026163.60 USD
8/7/2026166.37 USD
8/6/2026163.32 USD
8/5/2026155.97 USD
8/4/2026157.07 USD
8/3/2026148.34 USD
7/31/2026142.55 USD
7/30/2026138.91 USD
7/29/2026136.79 USD
7/27/2026140.82 USD
Access this data via the Eulerpool API

Novanta Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
590.62 M USD
55.89 M USD
44.52 M USD
Jan 1, 2021
706.79 M USD
64.05 M USD
50.33 M USD
Jan 1, 2022
860.90 M USD
107.46 M USD
74.05 M USD
Jan 1, 2023
881.66 M USD
123.31 M USD
72.88 M USD
Jan 1, 2024
949.25 M USD
124.29 M USD
64.09 M USD
Jan 1, 2025
980.60 M USD
91.11 M USD
53.83 M USD
Jan 1, 2026 (e)
1.13 B USD
187.75 M USD
135.55 M USD
Jan 1, 2027 (e)
1.31 B USD
217.08 M USD
160.27 M USD

Novanta Income Statement, Balance Sheet, Cash Flow Statement

Last updated Sep 10, 2026, 9:17 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026e2027e
0.270.340.360.370.380.520.610.630.590.710.860.880.950.981.131.31
-25.9625.836.742.472.9535.6817.851.95-5.7519.6621.812.447.723.2715.6115.89
42.0740.7641.2142.0942.1942.2342.5141.8541.3642.4943.9545.2944.3641.5341.5341.53
114.00139.00150.00157.00162.00220.00261.00262.00244.00300.00378.00399.00421.00407.00470.54545.30
15.0019.00-16.0028.0032.0064.0071.0055.0055.0064.00107.00123.00124.0091.00187.00217.00
5.545.57-4.407.518.3312.2811.568.799.329.0712.4413.9613.079.2916.5016.53
19.007.00-24.0035.0022.0060.0049.0040.0044.0050.0074.0072.0064.0053.00135.00160.00
-32.14-63.16-442.86-245.83-37.14172.73-18.33-18.3710.0013.6448.00-2.70-11.11-17.19154.7218.52
33.9434.6134.4134.8134.9934.8435.4935.6135.7935.8136.0036.0836.1538.6838.6838.68
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Novanta generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Novanta retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Novanta's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Novanta has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Novanta's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Novanta stock margins

The Novanta margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Novanta. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Novanta.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
41.40 %
9.46 %
7.54 %
Jan 1, 2021
42.49 %
9.06 %
7.12 %
Jan 1, 2022
43.96 %
12.48 %
8.60 %
Jan 1, 2023
45.36 %
13.99 %
8.27 %
Jan 1, 2024
44.41 %
13.09 %
6.75 %
Jan 1, 2025
41.59 %
9.29 %
5.49 %
Jan 1, 2026 (e)
41.59 %
16.57 %
11.96 %
Jan 1, 2027 (e)
41.59 %
16.53 %
12.20 %

Novanta Stock Revenue, EBIT, Earnings per Share

The Novanta earnings per share therefore indicates how much revenue Novanta has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
16.50 USD
1.56 USD
1.24 USD
Jan 1, 2021
19.74 USD
1.79 USD
1.41 USD
Jan 1, 2022
23.91 USD
2.99 USD
2.06 USD
Jan 1, 2023
24.44 USD
3.42 USD
2.02 USD
Jan 1, 2024
26.26 USD
3.44 USD
1.77 USD
Jan 1, 2025
25.35 USD
2.36 USD
1.39 USD
Jan 1, 2026 (e)
30.88 USD
4.85 USD
3.69 USD
Jan 1, 2027 (e)
35.78 USD
5.61 USD
4.37 USD

Novanta business model & stock analysis

Novanta Inc is a leading manufacturer of precision equipment and components, specializing in innovative solutions in laser processing, precision drives, optical technology, and medical technology. The company was founded in 1968 and has since grown into a global company with offices worldwide. Novanta Inc focuses on technological innovation and differentiated products in areas with higher growth potential than the general economy. They specialize in four interconnected business areas: medical technology, industrial manufacturing, imaging, and components/technologies. They are proud to provide industry-leading products based on performance, precision, and reliability, and they work closely with customers to develop tailored solutions. The company invests heavily in research and development and offers high levels of customer service and technical support. The medical technology sector supplies a variety of customers, from large hospital chains to small practices, with products such as surgical tools, critical monitoring systems, and telemedicine technology. In industrial manufacturing, Novanta Inc offers laser machines, automation systems, and precision components for various applications. In the imaging sector, they provide solutions for automation, optical imaging, and sensing. Lastly, in the components/technologies sector, they offer a range of products used in markets such as defense and robotics, including torque sensors, precision motors, laser optics, and motion control systems. Novanta Inc has a strong national and international presence and is dedicated to meeting customer needs through customized solutions. They continue to invest in research and development to develop industry-leading products that deliver high performance, reliability, and precision. The answer is: Novanta Inc is a leading manufacturer of precision equipment and components, specializing in innovative solutions in laser processing, precision drives, optical technology, and medical technology. They have grown into a global company with offices worldwide and offer tailored solutions to meet customer needs. They focus on technological innovation and differentiated products in sectors with higher growth potential.

Novanta SWOT Analysis

Strengths

Novanta Inc has several key strengths that contribute to its success in the market:

  • Strong product portfolio: Novanta offers a wide range of innovative products and solutions across multiple industries.
  • Technological expertise: The company has a highly skilled workforce with deep knowledge in advanced technologies.
  • Strong brand reputation: Novanta is well-known for its high-quality products and reliable customer service.
  • Global presence: The company has a strong international presence, allowing it to serve customers worldwide.

Weaknesses

Novanta Inc also faces certain weaknesses that pose challenges to its growth:

  • Dependence on specific markets: The company's revenue heavily relies on a few key sectors, making it vulnerable to economic fluctuations in those industries.
  • Reactive approach: Novanta sometimes struggles to proactively identify market trends and adapt its strategies accordingly.
  • Over-reliance on distribution partners: The company's reliance on third-party distributors may limit control over its products' market positioning.

Opportunities

Novanta Inc can leverage the following opportunities to fuel its growth:

  • Industry expansion: The demand for high-tech solutions is growing globally, providing Novanta with opportunities to expand into new markets and industries.
  • Technological advancements: Novanta can take advantage of emerging technologies, such as automation and artificial intelligence, to develop new innovative products.
  • Strategic partnerships: Collaborating with other companies in complementary fields can enhance Novanta's product offerings and market reach.

Threats

Novanta Inc should be cautious of the following potential threats:

  • Intense competition: The industry in which Novanta operates is highly competitive, with many established and emerging players vying for market share.
  • Economic downturns: Global economic uncertainties and recessions can impact customer spending, potentially reducing demand for Novanta's products.
  • Regulatory changes: Changes in regulations and compliance requirements could affect Novanta's operations and product development.

Novanta Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Novanta Employees
Details
Date
Novanta Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Novanta Segments

Novanta Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Laser Products
Precision Motion and Technologies
Medical Technology
Precision Motion
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Novanta Revenue by Segment (2/3)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Robotics and Automation
Photonics
Advanced Surgery
Precision Medicine
Vision
Precision Manufacturing
Laser products
Precision motion
Vision technologies
Medical technologies
Details
Date
Robotics and Automation
Photonics
Advanced Surgery
Precision Medicine
Vision
Precision Manufacturing
Laser products
Precision motion
Vision technologies
Medical technologies
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
177.73 M USD
64.79 M USD
0.00 USD
122.19 M USD
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
168.33 M USD
80.54 M USD
124.73 M USD
0.00 USD
Jan 1, 2016
0.00 USD
174.16 M USD
0.00 USD
0.00 USD
122.25 M USD
0.00 USD
0.00 USD
88.35 M USD
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
232.36 M USD
0.00 USD
0.00 USD
183.07 M USD
0.00 USD
0.00 USD
105.86 M USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
249.34 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
132.10 M USD
0.00 USD
0.00 USD
Jan 1, 2024
288.32 M USD
0.00 USD
208.75 M USD
249.87 M USD
0.00 USD
202.30 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
318.58 M USD
0.00 USD
242.44 M USD
237.32 M USD
0.00 USD
182.26 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Novanta Revenue by Segment (3/3)

  • 3 Years

  • 5 Years

  • Max

Vision
Details
Date
Vision
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.00 USD
Jan 1, 2016
0.00 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
232.90 M USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD

Novanta Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

United States
Rest of Europe
Germany
Rest of Asia-Pacific
China
Asia Pacific
D E
J P
Other Countries
Other Country
Details
Date
United States
Rest of Europe
Germany
Rest of Asia-Pacific
China
Europe
Asia Pacific
D E
J P
Other Countries
Other Country
Jan 1, 2017
220.58 M USD
81.00 M USD
68.00 M USD
84.73 M USD
56.13 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
10.85 M USD
0.00 USD
Jan 1, 2018
242.24 M USD
105.61 M USD
88.03 M USD
104.30 M USD
66.41 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
7.75 M USD
0.00 USD
Jan 1, 2019
254.28 M USD
129.64 M USD
82.03 M USD
89.59 M USD
59.51 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
11.05 M USD
0.00 USD
Jan 1, 2020
225.76 M USD
127.04 M USD
83.77 M USD
74.33 M USD
70.56 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
9.17 M USD
0.00 USD
Jan 1, 2021
270.83 M USD
138.86 M USD
101.87 M USD
89.20 M USD
95.05 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
10.99 M USD
0.00 USD
Jan 1, 2022
372.35 M USD
137.80 M USD
133.73 M USD
101.60 M USD
97.18 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
18.25 M USD
0.00 USD
Jan 1, 2024
487.11 M USD
128.87 M USD
123.24 M USD
107.05 M USD
84.56 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
18.40 M USD
0.00 USD
Jan 1, 2025
519.01 M USD
137.41 M USD
114.65 M USD
97.03 M USD
93.20 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
19.31 M USD
0.00 USD

Novanta Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Novanta historical P/E ratio, EBIT multiple, and P/S ratio

Novanta annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Novanta shares outstanding

The number of shares of Novanta was 38.68 M in 2025. This indicates how many shares Novanta is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
35.79 M Stocks
Jan 1, 2021
35.81 M Stocks
Jan 1, 2022
36.00 M Stocks
Jan 1, 2023
36.08 M Stocks
Jan 1, 2024
36.15 M Stocks
Jan 1, 2025
38.68 M Stocks
Jan 1, 2026 (e)
38.68 M Stocks
Jan 1, 2027 (e)
38.68 M Stocks

Novanta stock splits

In Novanta's history, there have been no stock splits.

Current Novanta forecasts and price targets in September 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
70.00 % (7)
Hold
30.00 % (3)
Sell
0.00 % (0)
12M Price Target
161.67
Last Price
145.76
Currency
USD
12M Return Potential
10.92 %
LTM Return
0 %

Novanta Analyst Rating Actions

DateFirmActionRatingReliability
5/13/2026
Baird
Baird
MaintainedOutperform62
3/30/2026
Baird
Baird
UpgradeNeutralOutperform62
8/11/2025
Baird
Baird
MaintainedNeutral62
3/3/2025
Baird
Baird
MaintainedNeutral62
11/6/2024
Baird
Baird
MaintainedNeutral62
8/7/2024
Baird
Baird
MaintainedNeutral62
5/11/2023
Baird
Baird
MaintainedNeutral62
5/11/2022
William Blair
William Blair
UpgradeMarket PerformOutperform
11/13/2020
Berenberg
Berenberg
MaintainedHold
5/13/2020
Baird
Baird
MaintainedNeutral62

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Novanta Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/5/20260.85USD-267.54 MUSD-2026 Q2
5/11/20260.79USD-258.46 MUSD-2026 Q1
2/24/20260.90USD-260.67 MUSD-2025 Q4
5/7/20240.66USD-216.58 MUSD-2024 Q1
2/28/20240.64USD-214.91 MUSD-2023 Q4
11/6/20230.91USD-232.49 MUSD-2023 Q3
8/7/20230.85USD-229.08 MUSD-2023 Q2
5/8/20230.79USD-220.82 MUSD-2023 Q1
2/27/20230.74USD-219.42 MUSD-2022 Q4
11/8/20220.76USD-218.61 MUSD-2022 Q3

EESG©

Eulerpool ESG Scorecard© for the Novanta stock

79/100
94
Environment
99
Social
44
Governance
E

Environment

20
Scope 1 - Direct Emissions1,520
Scope 2 - Indirect emissions from purchased energy6,075
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions7,595
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees40
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Novanta shareholder structure

% Name
12.68295%
BLACKROCK, INC.
BLACKROCK, INC.
11.80458%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
10.84198%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
6.74863%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.86193%
PRICE T ROWE ASSOCIATES INC /MD/
PRICE T ROWE ASSOCIATES INC /MD/
4.84086%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC
...

Novanta Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.2%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
10.19%
SHI CANADA INC.
SHI CANADA INC.
SEC ↗
9.97%
SUMITOMO HEAVY INDUSTRIES, LTD.
SUMITOMO HEAVY INDUSTRIES, LTD.
SEC ↗
9.20%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
7.70%
Limited
Limited
SEC ↗
7.50%
Franklin Resources, Inc. (13-2670991)
Franklin Resources, Inc. (13-2670991)
SEC ↗
7.01%
Vanguard Portfolio Management
Vanguard Portfolio Management
SEC ↗
6.54%
FMR Corp.
FMR Corp.
SEC ↗
6.54%
Edward C. Johnson 3d
Edward C. Johnson 3d
SEC ↗
6.54%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
6.02%
BARCLAYS GLOBAL INVESTORS, NA.
BARCLAYS GLOBAL INVESTORS, NA.
SEC ↗

Novanta Executives and Management Board

13 members · avg. age 56 · 31 % women

MG

Mr. Matthijs Glastra (56)

Chairman of the Board, Chief Executive Officer · since 2012

8.78 M USD

Management

RB

Mr. Robert Buckley (51)

Chief Financial Officer

3.91 M USD
JL

Mr. John Lesica (49)

Co-Chief Operating Officer - Medical Solutions

CR

Mr. Chuck Ravetto (54)

Co-Chief Operating Officer - Automation Enabling Technologies

RN

Mr. Ray Nash

Corporate Finance Leader, Investor Relations · since 2021

Board of Directors

LC

Mr. Lonny Carpenter (63)

Lead Independent Director

317,453.00 USD
FW

Mr. Frank Wilson (66)

Independent Director

302,453.00 USD
MM

Ms. Maxine Mauricio (54)

Independent Director

282,453.00 USD
TS

Mr. Thomas Secor (54)

Independent Director

282,453.00 USD
DS

Dr. Darlene Solomon (66)

Independent Director

277,453.00 USD
BH

Ms. Barbara Hulit (58)

Independent Director

277,154.00 USD

Frequently asked questions about Novanta

Novanta Inc operates under a diverse business model focused on precision technology solutions. The company specializes in designing and producing electro-optical and motion control components, subsystems, and systems for a wide range of industries. Novanta Inc's offerings include laser technologies, medical and advanced industrial solutions, and 3D imaging and metrology systems. By leveraging their expertise, Novanta Inc aims to empower customers with innovative solutions that enhance performance, productivity, and precision in their respective fields.

Novanta Inc is primarily active in the industries of precision motion control, photonics, and medical technologies.

The main competitors of Novanta Inc in the market are Danaher Corporation, Coherent Inc, and IPG Photonics.

Novanta Inc is a leading global supplier of precision photonic and motion control components and subsystems. Founded in 1968 as GSI Group, the company later rebranded as Novanta in 2016 to better reflect its strategic focus. Novanta Inc specializes in developing innovative products for medical and advanced industrial applications, catering to customers in various industries such as healthcare, life sciences, and industrial automation. With a rich history spanning over five decades, Novanta Inc has established a solid reputation for delivering cutting-edge solutions that enable its customers to achieve their goals efficiently and effectively.

Novanta Inc has achieved numerous significant milestones since its establishment. The company, recognized as a global leader in precision photonics solutions, has made remarkable progress. Novanta Inc successfully expanded its presence across various industries, such as medical and advanced industrial markets. They have consistently delivered innovative technologies, driving advancements in areas like medical diagnostics, laser processing, and 3D printing. Novanta Inc has also established strategic partnerships and acquired key businesses to enhance its product portfolio and market position. Their commitment to innovation, customer-centric approach, and continuous growth have contributed to Novanta Inc's notable achievements in the industry.

Novanta Inc is primarily present in various countries and regions. The company has a global presence, with key markets in North America, Europe, and Asia. This multinational corporation operates across multiple continents, serving customers from diverse industries in these regions. Novanta Inc's extensive geographical reach allows it to capitalize on opportunities and effectively meet the demands of customers worldwide.

Novanta Inc represents values of innovation, excellence, and collaboration. With a strong corporate philosophy focused on driving technological advancements, Novanta delivers cutting-edge solutions across its diverse product portfolio. The company consistently strives for superior customer satisfaction by providing high-quality, precision technologies to its global customer base. Novanta fosters a culture of innovation and teamwork, fostering collaboration both internally and with strategic partners. As an industry leader, Novanta Inc is dedicated to pushing boundaries and enabling advancements in industries such as medical and industrial markets.

Analysts currently set an average price target of 158.61 USD for the Novanta stock (median: 161.67 USD), implying +8.8 % versus the latest price. The consensus is based on 10 analyst ratings.

10 analysts currently rate the Novanta stock: 7 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Novanta to generate revenue of 1.13 B USD and earnings per share of 3.50 USD.

Converted at the current exchange rate, the Novanta share trades at 131.15 EUR (152.58 USD).

The Novanta share (NOVT) is listed on 4 stock exchanges, including: NASDAQ (NOVT), Frankfurt (1GSN.F), London (0VAG.L), London (0VAG.L).

Novanta Inc is a leading provider of precision solutions for advanced technology and scientific applications. The company offers a comprehensive product portfolio and a global network of sales and service centers to meet the needs of its customers. Novanta's business model is based on interconnected divisions, including Photonics, Precision Motion, and Automated Assembly Solutions, which provide optical technologies, precision mechanics and controls, and automation technologies respectively. The company also offers other specialized products and solutions, such as ultrasound and electromedical instruments. Novanta primarily serves OEMs in the medical technology, industrial automation, and scientific instrumentation sectors, and focuses on innovation and research and development to meet evolving customer demands. In summary, Novanta is a leading provider of precision solutions across various industries, with a diversified business model emphasizing innovation and customer satisfaction.

The expected revenue of Novanta is 1.13 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Novanta is 135.55 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Novanta is currently 43.54. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Novanta stock.

The price-to-sales ratio (P/S) of Novanta is currently 5.21. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Novanta stock.

The Eulerpool Quality Score for Novanta is 5/10.

The ISIN of Novanta is CA67000B1040. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Novanta is A2AJW7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Novanta is NOVT. The ticker symbol is used to trade Novanta shares on the stock exchange.

Novanta paid dividends every year for the past 0 years.

Novanta is assigned to the 'Information technology' sector.

The dividends of Novanta are distributed in USD.

All fundamentals and in-depth analysis of Novanta

Our stock analysis for Novanta stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novanta. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.